1. Nectar Lifesciences
stock logo

Nectar Lifesciences Share Price

NECLIFE

₹33.80+₹0.65 (1.96%) Past YearLast updated on 19 Apr, 2024 | 03:29 PM IST
₹32.25₹34.35
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

About

arrow

Market cap

Market Cap Switch₹747 Cr

Open

₹32.45

Close

₹33.15

Circuit range

₹39.75 - ₹26.55

Day range

₹32.25 - ₹34.35

Year range

₹16.50 - ₹45.70

Volume

1,72,310

Avg. traded

₹32.92

Revenue (12m)

₹1,632 Cr

Nectar LifesciencesNectar Lifesciences Limited is an India-based pharmaceutical company. The Company's business areas include active pharmaceutical ingredients (APIs) and intermediates, formulations/finished dosage formulations (FDF), menthol and mint derivatives, and empty hard gelatin capsules. The Company is engaged in the manufacturing of oral and sterile cephalosporin products. Its oral cephalosporins include cefixime, cefurozime axetil crystalline, cefuroxime axetil amorphous, cedpodoxime proxetil, cefprozil and cefdinir. Its sterile cephalosporins include cefotaxime sodium, ceftriaxone sodium, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate and cefepime arginine. Its capacities include cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium and ceftriaxone sodium. The Company offers contract manufacturing capabilities for solid dosage forms, such as tablets, capsules, dry powder oral suspension and granules and injectable for cephalosporins.

Read more

Nectar Lifesciences Key indicators

arrow

52 week high

₹45.70

52 week low

₹16.50

P/E ratio

91.27

P/B ratio

0.7

ROE

-2.09%

ROCE

2.06%

Dividend yield

--

Debt/Equity ratio

0.71

EPS

-1

Learn more

Investment checklist: (2/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

5.61%

Net profit margin

-1.29%

ROE

-2.09%

ROA

-0.99%

ROCE

2.06%

Learn more

Nectar Lifesciences Shareholder returns

arrow

1 day

+0.45%

1 week

-4.17%

1 month

+4.55%

3 months

-2.06%

1 year

+88.14%

3 years

+72.54%

5 years

+93.04%

Revenue statement

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Cash flow

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Balance sheet

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Nectar Lifesciences Share Price history

arrow
DayOpenCloseDay’s change
Fri, Apr 19 2024
₹32.45
₹33.30
+2.55%
Thu, Apr 18 2024
₹34.15
₹33.15
-3.02%
Tue, Apr 16 2024
₹32.25
₹34.15
+5.56%
Mon, Apr 15 2024
₹33.50
₹32.60
-2.76%
Fri, Apr 12 2024
₹34.70
₹33.85
-2.51%
Wed, Apr 10 2024
₹34.80
₹34.75
-0.14%
Tue, Apr 9 2024
₹35.45
₹34.85
-1.72%
Mon, Apr 8 2024
₹36.25
₹35.45
-2.26%

Shareholding info

arrow

Promoters (55.8%)

Mutual Funds (0%)

Retail and other (27.21%)

Foreign institutions-FII (16.98%)

Other domestic institutions (0.01%)

Promoters

Learn more

Events

Empty state

No data available at the moment

Frequently asked questions